MAY 18, 2016 10:36 AM PDT

Arctic Sponge Extract May Be Potent Against MRSA

WRITTEN BY: Xuan Pham
Turning back to nature’s marine medicine cabinet, scientists at the University of South Florida (USF) may have found a new chemical that can beat the formidable methicillin-resistant Staphylococcus aureus (MRSA) bacteria. The compound, named “darwinolide,” was extracted from the arctic sea sponge Dendrilla membranosa. The team hopes the new compound will give doctors the upper hand in hospital settings plagued by MRSA infections.
 
New compound in arctic sponge can kill MRSA
The Staphylococcus aureus bacteria are found on the skin and nose of most people – even healthy persons. Most of the time, Staph infections are minor and don’t warrant extensive treatments. However, Staph infections take a serious turn when the bacteria invade the bloodstream and major organs. Even more dangerous, some types of Staph, such as MRSA, have become resistant to antibiotics that are common in a doctor’s arsenal. As such, MRSA infections represent some of the biggest health risks for patients and their doctors.
 
"In recent years, MRSA has become resistant to vancomycin and threatens to take away our most valuable treatment option against staph infections," said Lindsey N. Shaw, USF microbiologist and study co-author.
 
Whereas highly-resistant MRSA used to be mostly confined to the health care settings, such as in hospitals, nursing homes, and dialysis centers – the resistant strain can now be found in high-traffic community areas too. Locker rooms, gyms, and schools also provide good breeding grounds for the MRSA and its spread through the community.
 

One of bacteria’s most effective defenses against antibiotics is its ability to form a biofilm, which are aggregated colonies that secrete a slimy substance that protects the bacteria against the environment. "Biofilms, formed by many pathogenic bacteria during infection, are a collection of cells coated in a variety of carbohydrates, proteins and DNA," said Shaw. "Up to 80 percent of all infections are caused by biofilms and are resistant to therapy. We desperately need new anti-biofilm agents to treat drug resistant bacterial infections like MRSA."
 
Indeed, by going to the ends of the Earth, they may have found an answer in the arctic sea sponge. The team’s leader, Bill Baker, has extensive experience with marine medicine, as he studies the chemical ecology of Antarctica to find natural compounds with pharmaceutical potential.
 
From freeze-dried Antarctic sponges, the team extracted and purified a chemical that they named darwinolide. The compound proved to be effective against the biofilm phase of MRSA, making it a promising compound against this difficult-to-treat infection.
 
"When we screened darwinolide against MRSA we found that only 1.6 percent of the bacterium survived and grew. This suggests that darwinolide may be a good foundation for an urgently needed antibiotic effective against biofilms," said Baker.
 
Despite growing advances in medicine and pharmaceuticals, MRSA account for over 80,000 hospital-acquired infections, leading to over 11,000 deaths every year. "We suggest that darwinolide may present a highly suitable scaffold for the development of urgently needed, novel, anti-biofilm-specific antibiotics," the authors concluded.

Additional source: EurekAlert!
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
SEP 11, 2019
Health & Medicine
SEP 11, 2019
Diagnosis and Treatment of Neurosarcoidosis
Sarcoidosis is a multisystem inflammatory disease characterized by the formation of non-caseating granulomas in the affected organs. The majority of p...
OCT 10, 2019
Cardiology
OCT 10, 2019
Parkinson's Disease is Present in the Blood
Parkinson's disease is a progressive disorder of the nervous system. Often starting with a barely noticeable tremor in one hand, the disease affects a...
OCT 16, 2019
Genetics & Genomics
OCT 16, 2019
A 'Molecular Clock' for Determining a Child's Age
This tool can aid in the diagnosis of developmental disorders, including autism spectrum disorder....
JAN 08, 2020
Clinical & Molecular DX
JAN 08, 2020
MicroRNA emerges as a biomarker for migraines
Intense, debilitating pain that can last for days. Nausea, numbness and sensitivity to light. For people who experience migraines, it’s frustrating t...
JAN 21, 2020
Clinical & Molecular DX
JAN 21, 2020
Brain scans of teens predict their risk of binge drinking
We’ve seen teenage binge drinking widely represented in popular culture. There is, however, a dark side to what many consider harmless fun. Mounting...
JAN 30, 2020
Genetics & Genomics
JAN 30, 2020
How To Choose The Right DNA Testing Kit For You
One of the most exciting scientific advancements in the past decade, at least in terms of its impact on pop culture, was the sudden accessibility of home D...
Loading Comments...